首页> 外国专利> CROSS-SPECIES-SPECIFIC PSCAXCD3,CD19XCD3,C-METXCD3,ENDOSIALINXCD3,EPCAMXCD3,IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSCAXCD3,CD19XCD3,C-METXCD3,ENDOSIALINXCD3,EPCAMXCD3,IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

机译:跨物种专用PSCAXCD3,CD19XCD3,C-METXCD3,ENDOSIALINXCD3,EPCAMXCD3,IGF-1RXCD3或FAPALPHAXCD3双特异性单链抗体

摘要

The present invention relates to a bispecific single chain antibody molecule comprising a first binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3 epsilon chain, wherein the epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs. 2, 4, 6, and 8, and a second binding domain capable of binding to an antigen selected from the group consisting of Prostate Stem Cell Antigen (PSCA), B-Lymphocyte antigen CD19 (CD19), hepatocyte growth factor receptor (C-MET), Endosialin, the EGF-like domain 1 of EpCAM, encoded by exon 2, Fibroblast activation protein alpha (FAP alpha) and Insulin-like growth factor I receptor (IGF-IR or IGF-1R). The invention also provides nucleic acids encoding said bispecific single chain antibody molecule as well as vectors and host cells and a process for its production. The invention further relates to pharmaceutical compositions comprising said bispecific single chain antibody molecule and medical uses of said bispecific single chain antibody molecule.
机译:本发明涉及双特异性单链抗体分子,其包含能够结合人和非黑猩猩灵长类CD3ε链表位的第一结合域,其中所述表位是包含在SEQ.ID.No.1中的氨基酸序列的一部分。身份证号码2、4、6和8,以及能够与选自前列腺干细胞抗原(PSCA),B淋巴细胞抗原CD19(CD19),肝细胞生长因子受体(C- MET),Endosialin,EpCAM的EGF样结构域1,由外显子2,成纤维细胞活化蛋白α(FAPα)和胰岛素样生长因子I受体(IGF-1R或IGF-1R)编码。本发明还提供了编码所述双特异性单链抗体分子的核酸以及载体和宿主细胞及其生产方法。本发明进一步涉及包含所述双特异性单链抗体分子的药物组合物和所述双特异性单链抗体分子的医学用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号